Shennon Biotechnologies

Develops a single-cell platform for rapid immunotherapy drug discovery.

Discussion
BiotechnologyPharmaceuticals shennonbio.com ↗

Company facts

Founded
2021
Employees
16
Headquarters
United States
Type
Private
Funding
Seed · $13M · 2023